Managing Increased Accessibility to Pharmacogenomic Data.
Publication
, Journal Article
Haga, SB
Published in: Clin Pharmacol Ther
November 2019
Duke Scholars
Published In
Clin Pharmacol Ther
DOI
EISSN
1532-6535
Publication Date
November 2019
Volume
106
Issue
5
Start / End Page
922 / 924
Location
United States
Related Subject Headings
- Risk Assessment
- Precision Medicine
- Pharmacology & Pharmacy
- Pharmacogenomic Testing
- Pharmacogenetics
- Patient Education as Topic
- Humans
- Health Knowledge, Attitudes, Practice
- Education, Pharmacy
- Education, Medical, Continuing
Citation
APA
Chicago
ICMJE
MLA
NLM
Haga, S. B. (2019). Managing Increased Accessibility to Pharmacogenomic Data. Clin Pharmacol Ther, 106(5), 922–924. https://doi.org/10.1002/cpt.1602
Haga, Susanne B. “Managing Increased Accessibility to Pharmacogenomic Data.” Clin Pharmacol Ther 106, no. 5 (November 2019): 922–24. https://doi.org/10.1002/cpt.1602.
Haga SB. Managing Increased Accessibility to Pharmacogenomic Data. Clin Pharmacol Ther. 2019 Nov;106(5):922–4.
Haga, Susanne B. “Managing Increased Accessibility to Pharmacogenomic Data.” Clin Pharmacol Ther, vol. 106, no. 5, Nov. 2019, pp. 922–24. Pubmed, doi:10.1002/cpt.1602.
Haga SB. Managing Increased Accessibility to Pharmacogenomic Data. Clin Pharmacol Ther. 2019 Nov;106(5):922–924.
Published In
Clin Pharmacol Ther
DOI
EISSN
1532-6535
Publication Date
November 2019
Volume
106
Issue
5
Start / End Page
922 / 924
Location
United States
Related Subject Headings
- Risk Assessment
- Precision Medicine
- Pharmacology & Pharmacy
- Pharmacogenomic Testing
- Pharmacogenetics
- Patient Education as Topic
- Humans
- Health Knowledge, Attitudes, Practice
- Education, Pharmacy
- Education, Medical, Continuing